Tim Healey brings a global perspective to pharmaceutical launch and commercialization across a dozen therapeutic categories. Tim’s executive experience includes serving as Chief Commercial Officer - COMPLETE Commercialization at EVERSANA, Senior Vice President, Commercial at AMAG Pharmaceuticals, Vice President/General Manager for US Virology at Abbott Laboratories/AbbVie, and Senior Vice President, Commercial at Lantheus. At EVERSANA Tim has led all aspects of commercial planning and launch operations from brand strategy to product distribution, across a wide range of biopharma companies. He has built 7 go-to-market plans for pre-commercial companies preparing to launch their first brand over the last 4-years. He is currently leading launch preparation efforts for a breakthrough ultra-rare product targeted to launch in late 2024.Tim orchestrated the launch of Lunesta® (Sleep) and generated more than 4 million prescriptions in the first year of launch. He has also launched Feraheme ® (Nephrology), as well as new indications for Allegra® (Allergy). He has won prestigious awards for launch excellence including Brandweek’s “Marketer of the Year”, and Medical Marketing a Media’s “Brand Team of the Year”. Tim received a Bachelor of Science degree from Boston College, and a Masters in Business Administration from Babson College where he was inducted into the Beta Gamma Sigma Scholastic Honorary Society.
Listed skills include Visionary, Clinical Trials, Cross Functional Team, Cardiology, and 27 others.
